Yun Zhao1, Chenhe Li2, Lu Huang1, and Liming Xia1
1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2Department of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Synopsis
Keywords: Myocardium, Cardiomyopathy
Motivation: The assessment of early morphology and functional reverse remodeling of the heart is significant for HOCM patient prognosis.
Goal(s): This study aimed to evaluate the early cardiac morphology and function in HOCM after transapical beating-heart septal myectomy (TA-BSM) using CMR.
Approach: 41 HOCM patients who underwent CMR before after TA-BSM were prospectively enrolled in the study. Preoperative and postoperative cardiac morphological and functional parameters were compared.
Results: LVEF, wall thickness, LVMI, and LVRI decreased after TA-BSM. The △LVOTG and baseline LVMI were independently associated with greater left ventricular mass regression.
Impact: Surgery relieves the mechanical stress
overload of the left ventricle (LV) and greatly improves the LV hyperdynamic
state. It is essential to evaluate left heart morphology and function
accurately after TA-BSM.
Introduction
Hypertrophic
cardiomyopathy (HCM) is an autosomal dominant cardiomyopathy with an incidence
of 0.2 to 0.5% and is characterized by asymmetric myocardial hypertrophy [1]. Hypertrophic
obstructive cardiomyopathy (HOCM) often causes severe symptoms and decreased labor
endurance, placing patients at high risk of sudden cardiac death (SCD) and
progressive heart failure (HF) [2]. Transapical beating-heart
septal myectomy (TA-BSM) [3] is a new type of precision ventricular septal myectomy
characterized by being minimally invasive and independent of the need for
extracorporeal circulation. This study aimed to evaluate the morphological and
functional parameters of the left heart before and after TA-BSM in HOCM
patients using CMR and to further explore the factors associated with reverse
remodeling.Methods
Study cohort
The study prospectively enrolled 80 HOCM
patients who underwent TA-BSM in Tongji Hospital from April 2022 to January 2023. All patients were diagnosed as
having HCM based on the published guidance.
Cardiac
MRI scanning protocol
All patients underwent a standard CMR
examination on a 3T system (MAGNETOM Skyra, Siemens Healthcare, Erlangen,
Germany). Cine images were acquired with ECG-gated and breath-holding using a
segmented, balanced, steady-state free-precession sequence.
MRI data
analysis
All CMR function
analyses were performed using
commercial cardiac software (CVI 42, version 5.14.0, Circle Cardiovascular
Imaging Inc., Canada). Left ventricular end-diastolic diameter (LVEDD) was
measured in the middle short-axial slice at the end-diastolic phase. Left
ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume
(LVESV), stroke volume (SV), cardiac output (CO), left ventricular ejection
fraction (LVEF), and left ventricular mass (LVM) were obtained through
end-diastolic and end-diastolic delineation. The left ventricular remodeling
index (LVRI) was calculated as: LVRI = LVM / LVEDV.
Statistical analysis
Statistical analysis of preoperative and postoperative CMR data was
performed using SPSS statistical software (version 25.0, IBM SPSS Inc.,
Chicago, IL). Parameters at baseline and follow-up CMR were compared using the
paired t-test or paired Wilcoxon signed-ranks test. Predictors of the left
ventricular mass index (LVMI) reduction and LVRI were calculated using a
stepwise multiple linear regression model entered as covariate factors. P<0.05 was considered
statistically significant.Results
Changes in morphology and function
SV, CI, LVMI, LVRI, LVEF, maximum wall thickness, maximum wall thickness
in non-surgical segments, and LVMI decreased after TA-BSM (all p < 0.05) (Fig. 2). The left
ventricular end-diastolic volume index (LVEDVI) and LVEDD decreased in patients with a sigmoid septum
postoperatively (82.7 ml/m2 vs. 72.8 ml/m2, 50.6 (48.2,
56.5) mm vs. 47.2 (42.7, 50.1) mm, both p < 0.001) but increased in patients
with reverse septal curvature (79.6 ml/m2 vs. 87.0 ml/m2,
44.9±1.1 mm vs. 51.3 ± 0.9, both p < 0.001)
LVMI and maximum wall thickness were significantly correlated with LVRI
preoperatively (rs = 0.734 and r = 0.679, both p < 0.001). After
TA-BSM, both remained significantly associated with LVRI (Fig. 3). n the multivariate analysis,△LVOTG
(adjusted β = 0.323, p = 0.018) and baseline LVMI (adjusted β = 0.436, p < 0.040) were independent predictors of LV mass
regression. In addition, the weight
of the resected myocardium (adjusted β
= 0.476, p = 0.005) and △mitral regurgitation
degree (adjusted β = -0.245, p = 0.040)
were associated with △LVRI.Discussion
In this study, we performed a pre- and postoperative structural and
functional analysis of the left heart during the TA-BSM procedure. There are
two primary mechanisms of myocardial hypertrophy. The first is when genetic
factors lead to cardiomyocyte hypertrophy and extracellular matrix fibrosis;
the other is secondary hypertrophy caused by increased afterload [4]. Genes are
the initiating factors that drive cardiomyocyte hypertrophy and extracellular
matrix proliferation. Hypertrophic myocardium has hypercontractility, resulting
in increased power output [5]. However, the normal turbulent state of blood
in the aorta is disturbed due to LVOT obstruction, particularly in patients
with basal ventricular septal hypertrophy. Abnormal ejection and the increased
contractile capacity of cardiomyocytes further increase left ventricular
systolic pressure. Abnormal circulation in the heart chambers and outflow tract
prompts further myocardial remodeling and aggravation of fibrosis.
Initially, myocardial remodeling was used to
describe changes in ventricular expansion and cardiomyocytes after myocardial
infarction [6]. Ventricular remodeling describes changes in the overall
geometry and deterioration of ventricular contractile function [4]. The
process of left ventricular remodeling is due to prolonged volume or pressure
overload, myocardial cell degeneration, and changes in the extracellular
composition [7].
Subsequently, the end-diastolic pressure-volume
relationship in the ventricle was introduced to evaluate structural remodeling
[8].Conclusions
Our study summarizes the
CMR findings indicative of left heart remodeling after TA-BSM. The structure
and function were recovered to some extent. Acknowledgements
No acknowledgement found.References
[1] Elliott PM, Anastasakis A, Borger MA,
Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna
WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C,
Rutten FH, Tillmanns C, Watkins H. 2014 ESC Guidelines on diagnosis and
management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and
Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology
(ESC). Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284.
Epub 2014 Aug 29. PMID: 25173338.
[2] Maron BJ, Maron MS. Hypertrophic
cardiomyopathy. Lancet. 2013 Jan 19;381(9862):242-55. doi:
10.1016/S0140-6736(12)60397-3. Epub 2012 Aug 6. PMID: 22874472.
[3]
Fang J, Liu Y, Zhu Y, Li R, Wang R, Wang DW, Song Y, Li C, Chen Y, Cheng L,
Zheng K, Zhao Y, Li S, Cheng C, Xia L, Chen X, Wan S, Wei X. First-in-Human
Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic
Obstructive Cardiomyopathy. J Am Coll Cardiol. 2023 Aug 15;82(7):575-586. doi:
10.1016/j.jacc.2023.05.052. PMID: 37558369.
[4] Kim GH, Uriel N, Burkhoff D. Reverse
remodelling and myocardial recovery in heart failure. Nat Rev Cardiol. 2018
Feb;15(2):83-96. doi: 10.1038/nrcardio.2017.139. Epub 2017 Sep 21. PMID:
28933783.
[5] Baxi AJ, Restrepo CS, Vargas D, Marmol-Velez
A, Ocazionez D, Murillo H. Hypertrophic Cardiomyopathy from A to Z: Genetics,
Pathophysiology, Imaging, and Management. Radiographics. 2016
Mar-Apr;36(2):335-54. doi: 10.1148/rg.2016150137. PMID: 26963450.
[6] Hochman JS, Bulkley BH. Expansion of
acute myocardial infarction: an experimental study. Circulation. 1982
Jun;65(7):1446-50. doi: 10.1161/01.cir.65.7.1446. PMID: 7074800.
[7] Sutton MS, Keane MG. Reverse remodelling
in heart failure with cardiac resynchronisation therapy. Heart. 2007
Feb;93(2):167-71. doi: 10.1136/hrt.2005.067967. Epub 2006 Apr 27. PMID:
16644861; PMCID: PMC1861399.
[8] Pfeffer JM, Pfeffer MA, Fletcher PJ,
Braunwald E. Progressive ventricular remodeling in rat with myocardial
infarction. Am J Physiol. 1991 May;260(5 Pt 2):H1406-14. doi:
10.1152/ajpheart.1991.260.5.H1406. PMID: 2035662.